Image de couverture de livre

Multicenter External Validation and Optimization of a Proposed Nomogram for Prostate‐Specific Membrane Antigen PET/CT Accuracy in Biochemical Recurrence

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Laura Chamorro Castillo, Inés Rivero Belenchón, Ignacio Puche Sanz, Rocío Saiz Marenco, Ana Victoria Ojeda Claro, Néstor Sánchez Martínez, Rafael Medina López, Alvaro Juárez Soto, Jose Luis Álvarez Ossorio, Emilio García Galisteo, Julia Carrasco Valiente, Bernardo Herrera Imbroda, Juan Moreno Jiménez, Juan Antonio Vallejo Casas, Antonio Rodríguez, Adrián Santiago Ortiz, Juan Pablo Campos Hernández, Enrique Gómez Gómez
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	The Prostate
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
par: Elizabeth Robinson, et autres
Publié: (2025)

Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide
par: Christian Andrés Martínez Osorio, et autres
Publié: (2025)

Enhancing Diagnostic Accuracy in Prostate Oncology: A Multidimensional Perspective on Prostate Specific Antigen Density
par: Shengyi Chen, et autres
Publié: (2025)

Mortality and Additional Treatment Rates in Pathologically High‐Risk Prostate Cancer With Prostate‐Specific Antigen Persistence at Robot‐Assisted Radical Prostatectomy: Long‐Term Report From Single Tertiary Referral Center
par: Alessandro Bertini, et autres
Publié: (2025)

Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy
par: Yuto Ono, et autres
Publié: (2025)

Prognostic Impact of Initial Prostate Specific Antigen Half‐Life After Abiraterone Acetate in High‐Volume Metastatic Hormone‐Sensitive Prostate Cancer: Who May Need Triplet Therapy?
par: Kotaro Suzuki, et autres
Publié: (2026)

Racial Disparities in the Use of MRI and PET Scan Among Medicare Beneficiaries With Prostate Cancer
par: Hanna Zurl, et autres
Publié: (2025)

Serum Levels of Prostate Specific Antigen, Free PSA, [‐2]proPSA, fPSA/tPSA Ratio, Prostate Health Index, and Glycosylation Patterns of Free PSA in Patients With Benign Prostatic Hyperplasia Pharmacotherapy: Limitations and Future Directions
par: Yitong Weng, et autres
Publié: (2025)

Individualized Precision Prostate Biopsy Strategy for Patients With PI‐RADS Score 2: A Retrospective Multicenter Study
par: Zhiyao Xu, et autres
Publié: (2025)

Development and Validation of a Nomogram for Predicting Pathological Upgrading in Men With Biopsy Gleason 3 + 3 Prostate Cancer Undergoing Radical Prostatectomy: A Population‐Based Study
par: Han Li, et autres
Publié: (2026)

[ 18 F] PSMA PET‐CT and [ 18 F] Choline PET‐CT in the Diagnosis of High‐Risk Localized Prostate Cancer: Comparation of Both Tests
par: M. A. Tárraga‐Honrubia, et autres
Publié: (2026)

Significant Effect of Carbon‐Ion Radiation Therapy Combined With Androgen Deprivation on Biochemical Recurrence Rates in High‐Risk Prostate Cancer Patients: A Two‐Center Controlled Trial Compare With X‐Ray External Beam Radiation Therapy
par: Xue Zhao, et autres
Publié: (2024)

Propensity Score Matched Analysis of External Beam Radiotherapy With or Without Focal Boost to Intraprostatic Lesions in Prostate Cancer
par: Cem Onal, et autres
Publié: (2025)

Efficacy of Serenoa repens Extract Combined With Alfuzosin Versus Alfuzosin Alone in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Multicenter Randomized Study
par: Giulio Bevilacqua, et autres
Publié: (2025)

Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer
par: Marta Victoria Lorenzo‐Sánchez, et autres
Publié: (2025)

Towards Precision Oncology: A New Predictive Machine Learning Model for Early Progression to Castration Resistant Prostate Cancer
par: Miguel Ángel Gómez‐Luque, et autres
Publié: (2025)

The Clinical Significance of Gallium‐68 PSMA‐11 PET‐Derived SUVmax in the Management of Metastatic Hormone‐Sensitive Prostate Cancer
par: Cevat İlteriş Kıkılı, et autres
Publié: (2026)

Incidental Brain Metastases From Prostate Cancer Diagnosed With PSMA PET/CT and MRI: A Case Series and Literature Review
par: Mark Willy L. Mondia, et autres
Publié: (2025)

Prostate cancer focal therapy: surgeon experience influences oncological results
par: Claudio Bovolenta Murta, et autres
Publié: (2024)

Evaluating the Heterogeneity of Advanced Prostate Cancer by 18F‐DCFPyL and 18F‐FDG PET/CT in a Prospective Cohort
par: GuangHao Chen, et autres
Publié: (2025)

Impact of Pelvic Lymph Node Dissection on Early Oncological Outcomes in Intermediate‐Risk Prostate Cancer Patients With Node‐Negative PSMA PET
par: Baris Esen, et autres
Publié: (2025)

Correction to “[Efficacy of Serenoa repens Extract Combined With Alfuzosin Versus Alfuzosin Alone in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Multicenter Randomized Study ( The Prostate , 2025). https://doi.org/10.1002/pros.70071]”
Publié: (2026)

Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo‐Controlled, Biomarker‐Enriched Trial in Patients With the SOD2 Ala/Ala Variant
par: A. Mandl, et autres
Publié: (2025)

Efficacy, Safety, and Cost‐Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non‐Metastatic Castration‐Resistant Prostate Cancer: A Multicenter Retrospective Study
par: Himawari Asanuma, et autres
Publié: (2026)

Impact of Concomitant Hormone Therapy on the Diagnostic Performance of 18F‐Piflufolastat PET/CT in Prostate Cancer Patients: A Sub‐Group Analysis of OSPREY Cohort B
par: Lawrence Saperstein, et autres
Publié: (2025)

Refining the CHAARTED Classification: Clinical Utility of a Novel Integrated Risk Stratification Model Incorporating Gleason Grade and Biochemical Markers in Japanese Patients With Metastatic Hormone‐Sensitive Prostate Cancer
par: Takanori Tokunaga, et autres
Publié: (2025)

Safety and Efficacy of Bipolar Transurethral Vaporization of the Prostate and Bipolar Transurethral Resection of the Prostate in the Management of Large Volume Benign Prostatic Hyperplasia: A Prospective Randomized Study
par: Amr M. Lotfy, et autres
Publié: (2026)

The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
par: Yifu Shi, et autres
Publié: (2025)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
par: Tatsuya Shimomura, et autres
Publié: (2026)

Nomograms for detecting lymph node metastasis detected with surgery—Can you name any birds other than crow?
par: Cem Onal, et autres
Publié: (2024)

Robot‐Assisted Salvage Prostatectomy: External Validation of the EAU Selection Criteria and Identification of the Optimal Candidate: A Junior ERUS/YAU Collaborative Study
par: Mike Wenzel, et autres
Publié: (2025)

Discovering the Prostate: Notes on History and Historiography
par: Diederik F. Janssen
Publié: (2025)

Evidence and Rationale for Prostate Cancer Screening
par: Takeshi Takahashi
Publié: (2025)

Spatial Characteristics of Intraductal Carcinoma of the Prostate
par: Rodolphe Dupuis, et autres
Publié: (2025)

Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
par: Charly Bâcle, et autres
Publié: (2025)

Prostatic Surgery With Preservation of the Supramonticular Tissue Versus Standard Surgery for Benign Prostatic Hyperplasia: A Systematic Review
par: Giuston Mendoza‐Chuctaya, et autres
Publié: (2025)

Safety and Efficacy of Intra‐Prostatic Injection of Betamethasone for Refractory Chronic Nonbacterial Prostatitis: A Prospective Cohort Clinical Study
par: Ahmed Yehia Abdelaziz, et autres
Publié: (2024)

Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single‐Institution Pilot Study
par: Cameron J. Britton, et autres
Publié: (2025)

Primary Analysis of (NCT03380806) a Phase II Randomized Trial of Stereotactic Body Radiotherapy Boost Versus Conventional Fractionation External Beam Radiotherapy Boost in Unfavorable‐Intermediate and High‐Risk Prostate Cancer
par: Andre Gouveia, et autres
Publié: (2025)

Real‐World Treatment Patterns Before and After Metastatic Castration–Resistant Prostate Cancer in Japan: Retrospective Analysis Using a Hospital‐Based, Multicenter Database
par: Masaki Shiota, et autres
Publié: (2026)